id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4020-0008,FDA,FDA-2015-E-4020,Letter from U.S. Patent and Trademark Office to Boehringer Ingelheim Corporation,Other,Letter(s),2020-09-08T04:00:00Z,2020,9,2020-09-08T04:00:00Z,,2020-09-08T19:48:27Z,,0,0,090000648484b351